These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 23084770

  • 1. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A, Pakkanen SH, Siitonen A, Karttunen R, Kantele JM.
    Vaccine; 2012 Nov 26; 30(50):7238-45. PubMed ID: 23084770
    [Abstract] [Full Text] [Related]

  • 2. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH, Kantele JM, Herzog C, Kantele A.
    Vaccine; 2014 Jan 23; 32(5):544-51. PubMed ID: 24342246
    [Abstract] [Full Text] [Related]

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 4. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 5. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH, Kantele JM, Kantele A.
    Scand J Immunol; 2014 Mar 14; 79(3):222-9. PubMed ID: 24383914
    [Abstract] [Full Text] [Related]

  • 6. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A, Pakkanen SH, Karttunen R, Kantele JM.
    PLoS One; 2013 Mar 14; 8(4):e60583. PubMed ID: 23593253
    [Abstract] [Full Text] [Related]

  • 7. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 14; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 8. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
    Pakkanen SH, Kantele JM, Rombo L, Kantele A.
    Scand J Immunol; 2017 Oct 14; 86(4):207-215. PubMed ID: 28675263
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Clin Immunol; 2016 Dec 14; 173():87-95. PubMed ID: 27634430
    [Abstract] [Full Text] [Related]

  • 10. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R, Simon R, Zafar SJ, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2012 Jun 14; 19(6):825-34. PubMed ID: 22492745
    [Abstract] [Full Text] [Related]

  • 11. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
    Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, Haworth K, Sie R, Green CA, Jeppesen CA, Moore M, Thompson BA, John T, Kingsley RA, Yu LM, Voysey M, Hindle Z, Lockhart S, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ.
    PLoS Negl Trop Dis; 2016 Aug 14; 10(8):e0004926. PubMed ID: 27533046
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
    Black R, Levine MM, Young C, Rooney J, Levine S, Clements ML, O'Donnell S, Hugues T, Germanier R.
    Dev Biol Stand; 1983 Aug 14; 53():9-14. PubMed ID: 6307787
    [Abstract] [Full Text] [Related]

  • 13. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec 14; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 14. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY, Tsang RS.
    Dev Biol Stand; 1983 Dec 14; 53():29-31. PubMed ID: 6873471
    [Abstract] [Full Text] [Related]

  • 15. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Dec 14; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 16. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.
    J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933
    [Abstract] [Full Text] [Related]

  • 17. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Mucosal Immunol; 2015 Nov 01; 8(6):1349-59. PubMed ID: 25872480
    [Abstract] [Full Text] [Related]

  • 18. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Goncalves R, Pasetti MF, Sztein MB.
    J Immunol; 2002 Aug 15; 169(4):2196-203. PubMed ID: 12165550
    [Abstract] [Full Text] [Related]

  • 19. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
    Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2014 Mar 15; 21(3):427-34. PubMed ID: 24429069
    [Abstract] [Full Text] [Related]

  • 20. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ, O'Shaughnessy CM, Siggins MK, Bobat S, Kingsley RA, Goulding DA, Crump JA, Reyburn H, Micoli F, Dougan G, Cunningham AF, MacLennan CA.
    PLoS One; 2016 Mar 15; 11(1):e0145945. PubMed ID: 26741681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.